352 related articles for article (PubMed ID: 26938441)
1. De Novo Synonymous Mutations in Regulatory Elements Contribute to the Genetic Etiology of Autism and Schizophrenia.
Takata A; Ionita-Laza I; Gogos JA; Xu B; Karayiorgou M
Neuron; 2016 Mar; 89(5):940-7. PubMed ID: 26938441
[TBL] [Abstract][Full Text] [Related]
2. Truncating variant burden in high-functioning autism and pleiotropic effects of LRP1 across psychiatric phenotypes.
Torrico B; Shaw AD; Mosca R; Vivó-Luque N; Hervás A; Fernàndez-Castillo N; Aloy P; Bayés M; Fullerton JM; Cormand B; Toma C
J Psychiatry Neurosci; 2019 Sep; 44(5):350-359. PubMed ID: 31094488
[TBL] [Abstract][Full Text] [Related]
3. Loss-of-function variants in schizophrenia risk and SETD1A as a candidate susceptibility gene.
Takata A; Xu B; Ionita-Laza I; Roos JL; Gogos JA; Karayiorgou M
Neuron; 2014 May; 82(4):773-80. PubMed ID: 24853937
[TBL] [Abstract][Full Text] [Related]
4. De novo mutations revealed by whole-exome sequencing are strongly associated with autism.
Sanders SJ; Murtha MT; Gupta AR; Murdoch JD; Raubeson MJ; Willsey AJ; Ercan-Sencicek AG; DiLullo NM; Parikshak NN; Stein JL; Walker MF; Ober GT; Teran NA; Song Y; El-Fishawy P; Murtha RC; Choi M; Overton JD; Bjornson RD; Carriero NJ; Meyer KA; Bilguvar K; Mane SM; Sestan N; Lifton RP; Günel M; Roeder K; Geschwind DH; Devlin B; State MW
Nature; 2012 Apr; 485(7397):237-41. PubMed ID: 22495306
[TBL] [Abstract][Full Text] [Related]
5. Exome sequencing in 53 sporadic cases of schizophrenia identifies 18 putative candidate genes.
Guipponi M; Santoni FA; Setola V; Gehrig C; Rotharmel M; Cuenca M; Guillin O; Dikeos D; Georgantopoulos G; Papadimitriou G; Curtis L; Méary A; Schürhoff F; Jamain S; Avramopoulos D; Leboyer M; Rujescu D; Pulver A; Campion D; Siderovski DP; Antonarakis SE
PLoS One; 2014; 9(11):e112745. PubMed ID: 25420024
[TBL] [Abstract][Full Text] [Related]
6. De novo truncating mutation in Kinesin 17 associated with schizophrenia.
Tarabeux J; Champagne N; Brustein E; Hamdan FF; Gauthier J; Lapointe M; Maios C; Piton A; Spiegelman D; Henrion E; ; Millet B; Rapoport JL; Delisi LE; Joober R; Fathalli F; Fombonne E; Mottron L; Forget-Dubois N; Boivin M; Michaud JL; Lafrenière RG; Drapeau P; Krebs MO; Rouleau GA
Biol Psychiatry; 2010 Oct; 68(7):649-56. PubMed ID: 20646681
[TBL] [Abstract][Full Text] [Related]
7. Patterns and rates of exonic de novo mutations in autism spectrum disorders.
Neale BM; Kou Y; Liu L; Ma'ayan A; Samocha KE; Sabo A; Lin CF; Stevens C; Wang LS; Makarov V; Polak P; Yoon S; Maguire J; Crawford EL; Campbell NG; Geller ET; Valladares O; Schafer C; Liu H; Zhao T; Cai G; Lihm J; Dannenfelser R; Jabado O; Peralta Z; Nagaswamy U; Muzny D; Reid JG; Newsham I; Wu Y; Lewis L; Han Y; Voight BF; Lim E; Rossin E; Kirby A; Flannick J; Fromer M; Shakir K; Fennell T; Garimella K; Banks E; Poplin R; Gabriel S; DePristo M; Wimbish JR; Boone BE; Levy SE; Betancur C; Sunyaev S; Boerwinkle E; Buxbaum JD; Cook EH; Devlin B; Gibbs RA; Roeder K; Schellenberg GD; Sutcliffe JS; Daly MJ
Nature; 2012 Apr; 485(7397):242-5. PubMed ID: 22495311
[TBL] [Abstract][Full Text] [Related]
8. Mutations of ANK3 identified by exome sequencing are associated with autism susceptibility.
Bi C; Wu J; Jiang T; Liu Q; Cai W; Yu P; Cai T; Zhao M; Jiang YH; Sun ZS
Hum Mutat; 2012 Dec; 33(12):1635-8. PubMed ID: 22865819
[TBL] [Abstract][Full Text] [Related]
9. Exome sequencing in multiplex autism families suggests a major role for heterozygous truncating mutations.
Toma C; Torrico B; Hervás A; Valdés-Mas R; Tristán-Noguero A; Padillo V; Maristany M; Salgado M; Arenas C; Puente XS; Bayés M; Cormand B
Mol Psychiatry; 2014 Jul; 19(7):784-90. PubMed ID: 23999528
[TBL] [Abstract][Full Text] [Related]
10. Leveraging blood serotonin as an endophenotype to identify de novo and rare variants involved in autism.
Chen R; Davis LK; Guter S; Wei Q; Jacob S; Potter MH; Cox NJ; Cook EH; Sutcliffe JS; Li B
Mol Autism; 2017; 8():14. PubMed ID: 28344757
[TBL] [Abstract][Full Text] [Related]
11. Genes with de novo mutations are shared by four neuropsychiatric disorders discovered from NPdenovo database.
Li J; Cai T; Jiang Y; Chen H; He X; Chen C; Li X; Shao Q; Ran X; Li Z; Xia K; Liu C; Sun ZS; Wu J
Mol Psychiatry; 2016 Feb; 21(2):290-7. PubMed ID: 25849321
[TBL] [Abstract][Full Text] [Related]
12. Systematic resequencing of X-chromosome synaptic genes in autism spectrum disorder and schizophrenia.
Piton A; Gauthier J; Hamdan FF; Lafrenière RG; Yang Y; Henrion E; Laurent S; Noreau A; Thibodeau P; Karemera L; Spiegelman D; Kuku F; Duguay J; Destroismaisons L; Jolivet P; Côté M; Lachapelle K; Diallo O; Raymond A; Marineau C; Champagne N; Xiong L; Gaspar C; Rivière JB; Tarabeux J; Cossette P; Krebs MO; Rapoport JL; Addington A; Delisi LE; Mottron L; Joober R; Fombonne E; Drapeau P; Rouleau GA
Mol Psychiatry; 2011 Aug; 16(8):867-80. PubMed ID: 20479760
[TBL] [Abstract][Full Text] [Related]
13. Identification of ultra-rare disruptive variants in voltage-gated calcium channel-encoding genes in Japanese samples of schizophrenia and autism spectrum disorder.
Wang C; Horigane SI; Wakamori M; Ueda S; Kawabata T; Fujii H; Kushima I; Kimura H; Ishizuka K; Nakamura Y; Iwayama Y; Ikeda M; Iwata N; Okada T; Aleksic B; Mori D; Yoshida T; Bito H; Yoshikawa T; Takemoto-Kimura S; Ozaki N
Transl Psychiatry; 2022 Feb; 12(1):84. PubMed ID: 35220405
[TBL] [Abstract][Full Text] [Related]
14. Identification of de novo Mutations in the Chinese Autism Spectrum Disorder Cohort via Whole-Exome Sequencing Unveils Brain Regions Implicated in Autism.
Yuan B; Wang M; Wu X; Cheng P; Zhang R; Zhang R; Yu S; Zhang J; Du Y; Wang X; Qiu Z
Neurosci Bull; 2023 Oct; 39(10):1469-1480. PubMed ID: 36881370
[TBL] [Abstract][Full Text] [Related]
15. Exome sequencing for bipolar disorder points to roles of de novo loss-of-function and protein-altering mutations.
Kataoka M; Matoba N; Sawada T; Kazuno AA; Ishiwata M; Fujii K; Matsuo K; Takata A; Kato T
Mol Psychiatry; 2016 Jul; 21(7):885-93. PubMed ID: 27217147
[TBL] [Abstract][Full Text] [Related]
16. Direct measure of the de novo mutation rate in autism and schizophrenia cohorts.
Awadalla P; Gauthier J; Myers RA; Casals F; Hamdan FF; Griffing AR; Côté M; Henrion E; Spiegelman D; Tarabeux J; Piton A; Yang Y; Boyko A; Bustamante C; Xiong L; Rapoport JL; Addington AM; DeLisi JL; Krebs MO; Joober R; Millet B; Fombonne E; Mottron L; Zilversmit M; Keebler J; Daoud H; Marineau C; Roy-Gagnon MH; Dubé MP; Eyre-Walker A; Drapeau P; Stone EA; Lafrenière RG; Rouleau GA
Am J Hum Genet; 2010 Sep; 87(3):316-24. PubMed ID: 20797689
[TBL] [Abstract][Full Text] [Related]
17. Scan statistic-based analysis of exome sequencing data identifies FAN1 at 15q13.3 as a susceptibility gene for schizophrenia and autism.
Ionita-Laza I; Xu B; Makarov V; Buxbaum JD; Roos JL; Gogos JA; Karayiorgou M
Proc Natl Acad Sci U S A; 2014 Jan; 111(1):343-8. PubMed ID: 24344280
[TBL] [Abstract][Full Text] [Related]
18. Interpreting the role of de novo protein-coding mutations in neuropsychiatric disease.
Gratten J; Visscher PM; Mowry BJ; Wray NR
Nat Genet; 2013 Mar; 45(3):234-8. PubMed ID: 23438595
[TBL] [Abstract][Full Text] [Related]
19. Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia.
Gauthier J; Siddiqui TJ; Huashan P; Yokomaku D; Hamdan FF; Champagne N; Lapointe M; Spiegelman D; Noreau A; Lafrenière RG; Fathalli F; Joober R; Krebs MO; DeLisi LE; Mottron L; Fombonne E; Michaud JL; Drapeau P; Carbonetto S; Craig AM; Rouleau GA
Hum Genet; 2011 Oct; 130(4):563-73. PubMed ID: 21424692
[TBL] [Abstract][Full Text] [Related]
20. A strategy to identify de novo mutations in common disorders such as autism and schizophrenia.
Julie G; Hamdan FF; Rouleau GA
J Vis Exp; 2011 Jun; (52):. PubMed ID: 21712793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
